<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TIH</journal-id>
<journal-id journal-id-type="hwp">sptih</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Ind Health</journal-id>
<journal-title>Toxicology and Industrial Health</journal-title>
<issn pub-type="ppub">0748-2337</issn>
<issn pub-type="epub">1477-0393</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0748233711432573</article-id>
<article-id pub-id-type="publisher-id">10.1177_0748233711432573</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Antinociceptive effect of <italic>Butea monosperma</italic> on vincristine-induced neuropathic pain model in rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Thiagarajan</surname>
<given-names>Venkata Rathina Kumar</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711432573">1</xref>
<xref ref-type="aff" rid="aff2-0748233711432573">2</xref>
<xref ref-type="corresp" rid="corresp1-0748233711432573"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shanmugam</surname>
<given-names>Palanichamy</given-names>
</name>
<xref ref-type="aff" rid="aff3-0748233711432573">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krishnan</surname>
<given-names>Uma Maheswari</given-names>
</name>
<xref ref-type="aff" rid="aff4-0748233711432573">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muthuraman</surname>
<given-names>Arunachalam</given-names>
</name>
<xref ref-type="aff" rid="aff5-0748233711432573">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Nirmal</given-names>
</name>
<xref ref-type="aff" rid="aff5-0748233711432573">5</xref>
</contrib>
</contrib-group>
<aff id="aff1-0748233711432573"><label>1</label>School of Chemical and Biotechnology, Sastra University, Thanjavur, Tamilnadu, India</aff>
<aff id="aff2-0748233711432573"><label>2</label>Department of Pharmacognosy, College of Pharmacy, Madurai Medical College, Madurai, Tamilnadu, India</aff>
<aff id="aff3-0748233711432573"><label>3</label>Department of Pharmaceutical Sciences and Research, Sankaralingam Bhuvaneshwari College of Pharmacy, Thiruthangal, Sivakasi, Tamilnadu, India</aff>
<aff id="aff4-0748233711432573"><label>4</label>Center for Nanotechnology and Advanced Biomaterials, School of Chemical and Biotechnology, Sastra University, Thanjavur, India</aff>
<aff id="aff5-0748233711432573"><label>5</label>Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India</aff>
<author-notes>
<corresp id="corresp1-0748233711432573">Venkata Rathina Kumar Thiagarajan, Department of Pharmacognosy, College of Pharmacy, Madurai Medical College, Madurai, Tamilnadu, India. Email: <email>vrkmmcmadurai@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2013</year>
</pub-date>
<volume>29</volume>
<issue>1</issue>
<fpage>3</fpage>
<lpage>13</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Neuropathic pain is a chronic neurodegenerative disease. It is well characterized by spontaneous pain, hyperalgesia, hypothesia, dysesthesia and allodynia. The present study was designed to investigate the antinociceptive potential of <italic>Butea monosperma</italic> on vincristine-induced painful neuropathy in rats. Vincristine was administered for induction of neuropathic pain in experimental animals. Hot plate, acetone drop, paw pressure, Von Frey hair and tail immersion tests were performed to assess the degree of thermal hyperalgesia, cold chemical allodynia, mechanical hyperalgesia and allodynia in the hind paw and tail thermal hyperalgesia, respectively, as an index of peripheral and central pain sensation. Tissue thiobarbituric acid reactive substances (TBARSs), reduced glutathione (GSH) and total calcium levels were estimated to assess the biochemical changes in the sciatic nerve tissue. Microscopically, histopathological changes were also observed in the sciatic nerve tissue. Ethanolic extract of <italic>B. monosperma</italic> leaves and pregabalin were administered for 14 consecutive days. Vincristine administration resulted in significant reduction in behavioural (i.e. hyperalgesia and allodynic pain sensation) changes along with a rise in the levels of TBARS, total calcium and decrease in GSH levels when compared with the normal control group. Moreover, significant histological changes were also observed. Pretreatment with <italic>B. monosperma</italic> significantly attenuated vincristine-induced development of painful behavioural, biochemical and histological changes in a dose-dependent manner, which is similar to that of pregabalin-pretreated group. <italic>B. monosperma</italic> ameliorated vincristine-induced painful neuropathy. It may be due to its potential of antioxidative, neuroprotective and calcium channel inactivation.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Butea monosperma</italic>
</kwd>
<kwd>neuropathic pain</kwd>
<kwd>pregabalin</kwd>
<kwd>total calcium</kwd>
<kwd>vincristine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0748233711432573">
<title>Introduction</title>
<p>The vinca alkoloids (vincristine and vinblastine) are the most common chemotherapeutic agents used to treat a wide variety of malignancies, including leukemia and lymphoma and prevents tumour cell replication through alteration of cytoskeletal structure and disorientation of microtubules (<xref ref-type="bibr" rid="bibr15-0748233711432573">Higuera and David Luo, 2004</xref>; <xref ref-type="bibr" rid="bibr36-0748233711432573">Park et al., 2010</xref>). Vincristine-induced painful peripheral neuropathy is the major dose-limiting side effect and requires discontinuation of treatment, greatly impacting on the survival of cancer patients (<xref ref-type="bibr" rid="bibr18-0748233711432573">Kaley and Deangelis, 2009</xref>; <xref ref-type="bibr" rid="bibr39-0748233711432573">Sandler et al., 1969</xref>). Experimental models of vincristine-induced peripheral neuropathic pain have been established in rodents using different systemic dosing schedules of vincristine (<xref ref-type="bibr" rid="bibr18-0748233711432573">Kaley and Deangelis, 2009</xref>; <xref ref-type="bibr" rid="bibr36-0748233711432573">Park et al., 2010</xref>). It clinically mimics chemotherapy-associated neuropathic pain in human (<xref ref-type="bibr" rid="bibr16-0748233711432573">Jaggi and Singh, 2010</xref>; <xref ref-type="bibr" rid="bibr28-0748233711432573">Muthuraman et al., 2008a</xref>). Some preclinical and clinical reports promised to prevent neuropathic pain against chemotherapy-associated neurotoxicity, but none are yet approved for routine usage for the management of neurotoxic effects (<xref ref-type="bibr" rid="bibr54-0748233711432573">Weimer and Sachdev, 2009</xref>). Vincristine administration-induced peripheral nerve injury is characterized by dysesthesia (abnormal and unpleasant sensation), hyperalgesia (an increased response to painful stimuli) and allodynia (pain in response to a stimulus that does not normally provoke pain; <xref ref-type="bibr" rid="bibr56-0748233711432573">Woolf and Mannion, 1999</xref>).</p>
<p>Conventional analgesic and antineuralgic agents such as tricyclic antidepressants (i.e. amitriptyline, nortriptyline and imipramine), anticonvulsants (i.e. phenytoin, carbamazepine, gabapentin, lamotrigine and topiramate) and opioids have been reported to produce antiallodynic effects in neuropathic pain (<xref ref-type="bibr" rid="bibr9-0748233711432573">Dworkin et al., 2010</xref>; <xref ref-type="bibr" rid="bibr24-0748233711432573">Lee and Nandi, 2010</xref>). However, these medications have been documented as a wide spectrum of adverse effects which limit their full clinical exploitation in amelioration of the neuropathic pain (<xref ref-type="bibr" rid="bibr6-0748233711432573">Carol and Jane, 2006</xref>; <xref ref-type="bibr" rid="bibr55-0748233711432573">Wiffen et al., 2010</xref>). Various herbal medicines (e.g. <italic>Cannabis sativa</italic>, <italic>Ginkgo biloba</italic>, <italic>Ocimum sanctum</italic>, <italic>Aconiti tuber</italic>, <italic>Phyllanthus emblica</italic> and <italic>Nigella sativa</italic>) have been reported to possess the therapeutic potential for the management of various experimental models of neuropathic pain (<xref ref-type="bibr" rid="bibr21-0748233711432573">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bibr29-0748233711432573">Muthuraman et al., 2008b</xref>). Clinical reports have also claimed beneficial effects of herbal medicines in neuropathic pain conditions (<xref ref-type="bibr" rid="bibr11-0748233711432573">Ellis et al., 2009</xref>; <xref ref-type="bibr" rid="bibr34-0748233711432573">Nurmikko et al., 2007</xref>). Therefore, novel research urges to explore the newer herbal medicine in the management of neuropathic pain.</p>
<p>
<italic>Butea monosperma </italic>(family: <italic>Fabaceae</italic>) also known as ‘Flame of the Forest’, is distributed in deciduous forest and in open areas (<xref ref-type="bibr" rid="bibr14-0748233711432573">Lavhale and Mishra, 2007</xref>). The leaves, flowers, stem bark and seeds of <italic>B. monosperma</italic> have been used in traditional medicine as antidiabetic, antimicrobial, arthritis and wound healing actions (<xref ref-type="bibr" rid="bibr22-0748233711432573">Krithikar and Basu, 1995</xref>; <xref ref-type="bibr" rid="bibr53-0748233711432573">Varier, 1995</xref>).</p>
<p>Moreover, some traditional ayurvedic formulation of herbal species, that is, <italic>Emblica officinalis</italic>, <italic>Piper longum </italic>and<italic> B. monosperma</italic> have been documented as a nervine tonic and used for a life span of 100 years with full vigour, cognitive functions and to preserve youth (<xref ref-type="bibr" rid="bibr1-0748233711432573">Adams et al., 2007</xref>; <xref ref-type="bibr" rid="bibr26-0748233711432573">Manyam, 1999</xref>). Pippali rasayana (an ayurvedic herbal medicine) prepared from <italic>Piper longum </italic>and <italic>B. monosperma </italic>has been proved to play a major role in the immunomodulatory actions (<xref ref-type="bibr" rid="bibr2-0748233711432573">Agarwal et al., 1994</xref>, <xref ref-type="bibr" rid="bibr3-0748233711432573">1997</xref>).</p>
<p>Experimentally, it has been proved that the leaves of <italic>B. monosperma</italic> possess the therapeutic potential role in the management of inflammation, epilepsy, anxiety, tumourogenesis and diabetes (<xref ref-type="bibr" rid="bibr20-0748233711432573">Kasture et al., 2000</xref>; <xref ref-type="bibr" rid="bibr27-0748233711432573">Mengi and Deshpande, 1995</xref>; <xref ref-type="bibr" rid="bibr41-0748233711432573">Sehrawat and Sultana, 2006</xref>; <xref ref-type="bibr" rid="bibr43-0748233711432573">Shahavi and Desai, 2008</xref>; <xref ref-type="bibr" rid="bibr44-0748233711432573">Sharma and Garg, 2009</xref>; <xref ref-type="bibr" rid="bibr48-0748233711432573">Soman et al., 2004</xref>). <italic>B. monosperma </italic>leaves possess the biologically active secondary metabolites such as euphane triterpenoid, flavonoids, tannins and phytosterols (<xref ref-type="bibr" rid="bibr46-0748233711432573">Shukla et al., 2002</xref>). Fresh decoction of <italic>B. monosperma</italic> is commonly used to relieve muscular pain, joint pain and severe headache in some areas of Thiruvannamalai, Theni and Madurai regions in Tamil Nadu, India. An ayurvedic formulation namely Mahanarayana taila is used to treat neuralgia, which is prepared from this plant (<xref ref-type="bibr" rid="bibr4-0748233711432573">Anonymous, 2006</xref>). However, experimentally, its analgesic potential in neuropathic pain remains unexplored.</p>
<p>Therefore, the present study was designed to investigate the antinociceptive potential of <italic>B. monosperma</italic> on vincristine-induced painful neuropathy in rats. Pregabalin (Lyrica™, Pfizer, India.) binds to the α2-δ site of an auxiliary subunit of voltage-gated calcium channels (N-type) in the central nervous system, inhibiting excitatory neurotransmitter release, and it has been reported to possess the potential management of neuropathic pain (<xref ref-type="bibr" rid="bibr31-0748233711432573">Muthuraman et al., 2010</xref>). Therefore, pregabalin served as a positive control in this study.</p>
</sec>
<sec id="section2-0748233711432573" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-0748233711432573">
<title>Plant material and extraction</title>
<p>Fresh leafy parts of <italic>B. monosperma</italic> were collected from Madurai and authenticated. Plant sample has been kept in the Department of Pharmacognosy (Voucher specimen no: BM. 001/2007-2008), Madurai Medical College, Madurai. The fresh leaves of <italic>B. monosperma</italic> was shade dried and reduced to coarse powder (sieve no. 10/40). The powdered leaves of <italic>B. monosperma </italic>(500 g) were defatted with petroleum ether and then extracted with ethanol (95%) in a Soxhlet apparatus as described by <xref ref-type="bibr" rid="bibr50-0748233711432573">Suzgec-Selcuk and Birteksoz (2010</xref>). Ethanolic extract was concentrated under reduced pressure until dryness (yield 14.56%).</p>
</sec>
<sec id="section4-0748233711432573">
<title>Chemicals</title>
<p>5,5′-Dithio, bis(2-nitrobenzoic acid), bovine serum albumin and reduced glutathione (GSH) were purchased from Sisco Research Laboratories (Mumbai). Thiobarbituric acid was purchased from Loba Chemie (Mumbai). All other reagents were used in analytical grade.</p>
</sec>
<sec id="section5-0748233711432573">
<title>Animals</title>
<p>Wistar rats of either sex (180–250 g) were maintained on standard laboratory diet and water ad libitum. They were housed in the departmental animal house and exposed to 12 h light and dark cycle. The experimental protocol was approved by Institutional Animal Ethics Committee and animal care was as per the guidelines of Committee For the Purpose of Control and Supervision of Experiments on Animals (Ref. No. 2360/E2/4/2010).</p>
<sec id="section6-0748233711432573">
<title>Induction of peripheral neuropathy by vincristine</title>
<p>Painful peripheral neuropathy was induced in rats by the administration of vincristine sulfate (50 μg/kg; intraperitoneally (IP) once a day) for 10 consecutive days as described by <xref ref-type="bibr" rid="bibr47-0748233711432573">Siau and Bennett (2006</xref>).</p>
</sec>
<sec id="section6a-0748233711432573">
<title>Experimental protocol</title>
<p>Nine groups, each comprising six Wistar rats, were employed in the present study.</p>
<list list-type="order">
<list-item>
<p>Group I. Rats were not subjected to any drug or vehicle administration.</p>
</list-item>
<list-item>
<p>Group II. Rats were administered with vincristine (50 µg/kg; IP for 14 days).</p>
</list-item>
<list-item>
<p>Group III. Rats were administered with normal saline for 14 days.</p>
</list-item>
<list-item>
<p>Group IV. Rats were administered with ethanolic extract of B. monosperma (400 mg/kg; orally (p.o.)) to normal rats, for 14 days.</p>
</list-item>
<list-item>
<p>Group V. Rats were administered with pregabalin (10 mg/kg; p.o.) to normal rats, for 14 days.</p>
</list-item>
<list-item>
<p>Groups VI–VIII. Rats were administered with ethanolic extract of B. monosperma (200, 300 and 400 mg/kg; p.o.) 1 h before each vincristine injection, for 14 days.</p>
</list-item>
<list-item>
<p>Groups IX. Rats were administered with pregabalin (10 mg/kg; p.o.) 1 h before each vincristine injection, for 14 days.</p>
</list-item>
</list>
<p>The behavioural tests were performed on different time intervals, that is, 0, 1, 3, 6, 9, 12, 15, 18 and 21 days. Thereafter, all the animals were killed and subjected to biochemical estimation of the total protein, thiobarbituric acid reactive substance (TBARS), total calcium and reduced GSH in sciatic nerve tissue sample.</p>
</sec>
</sec>
<sec id="section7-0748233711432573">
<title>Behavioural assessment</title>
<p>Paw heat thermal sensitivity of the hind paw was assessed using Eddy’s hot plate method by <xref ref-type="bibr" rid="bibr10-0748233711432573">Eddy et al. (1950</xref>). Paw cold chemical thermal sensitivity of the hind paw was assessed using acetone drop method as described by <xref ref-type="bibr" rid="bibr8-0748233711432573">Choi et al. (1994</xref>). Paw mechanical sensation of the hind paw as an index of mechanical hyperalgesic test was assessed by the pressure stimulation method as described by <xref ref-type="bibr" rid="bibr37-0748233711432573">Randall and Selitto (1957</xref>). Paw mechanical sensation of the hind paw as an index of mechanical allodynia was assessed as described by <xref ref-type="bibr" rid="bibr7-0748233711432573">Chaplan et al. (1994</xref>). Spinal thermal sensitivity was assessed by the tail immersion test as described by <xref ref-type="bibr" rid="bibr33-0748233711432573">Necker and Hellon (1978</xref>).</p>
</sec>
<sec id="section8-0748233711432573">
<title>Biochemical estimation of markers of oxidative stress</title>
<p>At the end of the study protocol, animals were killed by cervical dislocation and the sciatic nerve was immediately isolated from the body. The sciatic nerve homogenate (10%, w/v) was prepared with 0.1 M Tris-HCl buffer (pH 7.4) and the supernatant of the homogenate was used to estimate total protein content, according to the method by <xref ref-type="bibr" rid="bibr25-0748233711432573">Lowry et al. (1951</xref>); TBARSs (malondialdehyde (MDA)), as described by <xref ref-type="bibr" rid="bibr35-0748233711432573">Okhawa et al. (1979</xref>); reduced GSH, as described by <xref ref-type="bibr" rid="bibr12-0748233711432573">Ellman (1959</xref>), and total calcium content, as described by <xref ref-type="bibr" rid="bibr42-0748233711432573">Severinghaus and Ferrebee (1950</xref>).</p>
<sec id="section9-0748233711432573">
<title>Histopathological evaluation</title>
<p>Samples of sciatic nerve were stored in the fixative solution (10% formalin) and cut into 4-µm thickness. Staining was done using hematoxylin and eosin as described by <xref ref-type="bibr" rid="bibr49-0748233711432573">Sudoh et al. (2004</xref>). Nerve sections were analyzed qualitatively under light microscope (×450) for axonal degeneration.</p>
</sec>
<sec id="section10-0748233711432573">
<title>Statistical analysis</title>
<p>All the results were expressed as mean ± SEM. The data from the behavioural results were statistically analyzed by two-way analysis of variance (ANOVA) followed by Bonferonni’s post hoc test using Graph pad prism Version-5.0 software. The data from the biochemical results were statistically analyzed by one-way ANOVA followed by Tukey’s multiple range tests. The <italic>p</italic> &lt; 0.05 was considered to be statistically significant.</p>
</sec>
</sec>
</sec>
<sec id="section11-0748233711432573">
<title>Results</title>
<sec id="section12-0748233711432573">
<title>Effect of <italic>B. monosperma</italic> on paw heat hyperalgesia</title>
<p>Vincristine administration resulted in significant development of noxious thermal hyperalgesia, noted by the decrease in hind paw withdrawal threshold, after day 3 when compared with normal control. Administration of ethanolic extract of <italic>B. monosperma </italic>(200, 300 and 400 mg/kg; p.o.) significantly attenuated vincristine-induced decrease in the nociceptive threshold for thermal hyperalgesia in a dose-dependent manner. Treatment of pregabalin also produced similar effects. However, statistically significant attenuation was recorded only in the groups treated with medium and high dose of <italic>B. monosperma</italic>. Furthermore, vehicle, <italic>B. monosperma </italic>per se and pregabalin did not show any significant effect on heat hyperalgesic test (<xref ref-type="fig" rid="fig1-0748233711432573">Figure 1</xref>).</p>
<fig id="fig1-0748233711432573" position="float">
<label>Figure 1.</label>
<caption>
<p>Effect of <italic>Butea monosperma</italic> on paw heat hyperalgesia. Digits within parentheses indicate dose in mg/kg. Data were expressed as mean ± SEM, <italic>n </italic>= 6 rats per group. <sup>a</sup>
<italic>p</italic> &lt; 0.05 versus normal control group. <sup>b</sup>
<italic>p</italic> &lt; 0.05 versus <italic>B. monosperma</italic> control group. <sup>c</sup>
<italic>p</italic> &lt; 0.05 versus pregabalin-treated group.</p>
</caption>
<graphic xlink:href="10.1177_0748233711432573-fig1.tif"/>
</fig>
</sec>
<sec id="section13-0748233711432573">
<title>Effect of <italic>B. monosperma</italic> on paw cold allodynia</title>
<p>Vincristine administration resulted in significant development of non-noxious cold chemical allodynia, noted by the decrease in the left hind paw withdrawal threshold, after day 3 when compared with normal control. Administration of ethanolic extract of <italic>B. monosperma</italic> (200, 300 and 400 mg/kg; p.o.) significantly attenuated vincristine-induced decrease in the nociceptive threshold for thermal allodynia in a dose-dependent manner. Treatment of pregabalin also produced similar effects. However, statistically significant attenuation was recorded in only the groups treated with medium and high dose of <italic>B. monosperma</italic>. Furthermore, vehicle, <italic>B. monosperma </italic>per se and pregabalin did not show any significant effect on cold chemical allodynic test (<xref ref-type="fig" rid="fig2-0748233711432573">Figure 2</xref>).</p>
<fig id="fig2-0748233711432573" position="float">
<label>Figure 2.</label>
<caption>
<p>Effect of <italic>Butea monosperma</italic> on paw cold allodynia. Digits in parentheses indicate dose in mg/kg. Data were expressed as mean ± SEM, <italic>n</italic> = 6 rats per group. <sup>a</sup>
<italic>p</italic> &lt; 0.05 versus normal control group. <sup>b</sup>
<italic>p</italic> &lt; 0.05 versus <italic>B. monosperma</italic> control group. <sup>c</sup>
<italic>p</italic> &lt; 0.05 versus pregabalin-treated group.</p>
</caption>
<graphic xlink:href="10.1177_0748233711432573-fig2.tif"/>
</fig>
</sec>
<sec id="section14-0748233711432573">
<title>Effect of <italic>B. monosperma</italic> on paw mechanical hyperalgesia</title>
<p>Vincristine administration resulted in significant development of noxious static mechanical hyperalgesia, noted by the decrease in the left hind paw withdrawal threshold, after day 3 when compared with normal control. Administration of ethanolic extract of <italic>B. monosperma </italic>(200, 300 and 400 mg/kg; p.o.) significantly attenuated vincristine-induced decrease in the nociceptive threshold for mechanical hyperalgesia in a dose-dependent manner. Treatment of pregabalin also produced similar effects. However, statistically significant attenuation was recorded only in groups treated with medium and high dose of <italic>B. monosperma</italic>. Furthermore, vehicle, <italic>B. monosperma </italic>per se and pregabalin did not show any significant effect on mechanical hyperalgesic test (<xref ref-type="fig" rid="fig3-0748233711432573">Figure 3</xref>).</p>
<fig id="fig3-0748233711432573" position="float">
<label>Figure 3.</label>
<caption>
<p>Effect of <italic>Butea monosperma </italic>on paw mechanical hyperalgesia. Digits in parentheses indicate dose in mg/kg. Data were expressed as mean ± SEM, <italic>n</italic> = 6 rats per group. <sup>a</sup>
<italic>p</italic> &lt; 0.05 versus normal control group. <sup>b</sup>
<italic>p</italic> &lt; 0.05 versus <italic>B. monosperma</italic> control group. <sup>c</sup>
<italic>p</italic> &lt; 0.05 versus pregabalin-treated group.</p>
</caption>
<graphic xlink:href="10.1177_0748233711432573-fig3.tif"/>
</fig>
</sec>
<sec id="section15-0748233711432573">
<title>Effect of <italic>B. monosperma</italic> on paw mechanical allodynia</title>
<p>Vincristine administration resulted in significant development of non-noxious tactile mechanical allodynia, noted by the decrease in the left hind paw withdrawal threshold, after day 3 when compared with normal control. Administration of ethanolic extract of <italic>B. monosperma </italic>(200, 300 and 400 mg/kg; p.o.) significantly attenuated vincristine-induced decrease in the nociceptive threshold for mechanical allodynia in a dose-dependent manner. Treatment of pregabalin also produced similar effects. However, statistically significant attenuation was recorded only with medium and high dose of <italic>B. monosperma</italic>-treated groups. Furthermore, vehicle, <italic>B. monosperma </italic>per se and pregabalin did not show any significant effect on mechanical allodynic test (<xref ref-type="fig" rid="fig4-0748233711432573">Figure 4</xref>).</p>
<fig id="fig4-0748233711432573" position="float">
<label>Figure 4.</label>
<caption>
<p>Effect of <italic>Butea monosperma</italic> on paw mechanical allodynia. Digits in parentheses indicate dose in mg/kg. Data were expressed as mean ± SEM, <italic>n</italic> = 6 rats per group. <sup>a</sup>
<italic>p</italic> &lt; 0.05 versus normal control group. <sup>b</sup>
<italic>p</italic> &lt; 0.05 versus <italic>B. monosperma</italic> control group. <sup>c</sup>
<italic>p</italic> &lt; 0.05 versus pregabalin-treated group.</p>
</caption>
<graphic xlink:href="10.1177_0748233711432573-fig4.tif"/>
</fig>
</sec>
<sec id="section16-0748233711432573">
<title>Effect of <italic>B. monosperma</italic> on tail heat hyperalgesia</title>
<p>Vincristine administration resulted in significant development of noxious thermal hyperalgesia, noted by the decrease in the tail withdrawal threshold, after day 3 when compared with normal control. Administration of ethanolic extract of <italic>B. monosperma </italic>(200, 300 and 400 mg/kg; p.o.) significantly attenuated vincristine-induced decrease in the nociceptive threshold for mechanical hyperalgesia in a dose-dependent manner. Treatment of pregabalin also produced similar effects. However, statistically significant attenuation was recorded only in groups with medium and high dose of <italic>B. monosperma</italic>. Furthermore, vehicle, <italic>B. monosperma </italic>per se and pregabalin did not show any significant effect on tail heat hyperalgesic test (<xref ref-type="fig" rid="fig5-0748233711432573">Figure 5</xref>).</p>
<fig id="fig5-0748233711432573" position="float">
<label>Figure 5.</label>
<caption>
<p>Effect of <italic>Butea monosperma</italic> on tail heat hyperealgesia. Digits in parentheses indicate dose in mg/kg. Data were expressed as mean ± SEM, <italic>n</italic> = 6 rats per group. <sup>a</sup>
<italic>p</italic> &lt; 0.05 versus normal control group. <sup>b</sup>
<italic>p</italic> &lt; 0.05 versus <italic>B. monosperma</italic> control group. <sup>c</sup>
<italic>p</italic> &lt; 0.05 versus pregabalin-treated group.</p>
</caption>
<graphic xlink:href="10.1177_0748233711432573-fig5.tif"/>
</fig>
</sec>
<sec id="section17-0748233711432573">
<title>Effect of <italic>B. monosperma</italic> on tissue biomarker changes</title>
<p>Vincristine administration resulted in significant rise in TBARS, total calcium levels and decreased in the levels of reduced GSH, after day 21 when compared with normal control. However, total protein levels were not affected significantly as a result of vincristine. Administration of the ethanolic extract of <italic>B. monosperma </italic>(200, 300 and 400 mg/kg; p.o.) significantly attenuated vincristine-induced rise in sciatic nerve tissue MDA, total calcium and decrease in reduced GSH levels in a dose-dependent manner. However, <italic>B. monosperma</italic> resulted in normalization of vincristine-induced biochemical abnormalities in a significant manner. Treatment of pregabalin also produced similar effects. Furthermore, vehicle, <italic>B. monosperma </italic>per se and pregabalin did not show any significant effect on oxidative stress markers (<xref ref-type="table" rid="table1-0748233711432573">Table 1</xref>).</p>
<table-wrap id="table1-0748233711432573" position="float">
<label>Table 1.</label>
<caption>
<p>Effect of <italic>Butea monosperma</italic> on tissue biomarker changes.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table1-0748233711432573" xlink:href="10.1177_0748233711432573-table1.tif"/>
<table>
<thead>
<tr>
<th>Groups</th>
<th>MDA (nmol/mg of protein)</th>
<th>GSH (µg/mg of protein)</th>
<th>Total calcium (ppm/mg of protein)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Normal</td>
<td>3.18 ± 0.61</td>
<td>76.19 ± 1.92</td>
<td>2.62 ± 0.31</td>
</tr>
<tr>
<td>VIN</td>
<td>4.57 ± 0.53<sup>b</sup>
</td>
<td>47.57 ± 3.68<sup>b</sup>
</td>
<td>21.48 ± 0.25<sup>b</sup>
</td>
</tr>
<tr>
<td>Vehicle in VIN</td>
<td>4.53 ± 0.18<sup>b</sup>
</td>
<td>48.32 ± 3.92<sup>b</sup>
</td>
<td>20.71 ± 0.48<sup>b</sup>
</td>
</tr>
<tr>
<td>
<italic>B. monosperma</italic> (400 mg/kg) per se</td>
<td>3.21 ± 0.46</td>
<td>75.83 ± 2.39</td>
<td>2.73 ± 0.26</td>
</tr>
<tr>
<td>Pregabalin (10 mg/kg) per se</td>
<td>3.20 ± 0.51</td>
<td>76.13 ± 2.04</td>
<td>2.82 ± 0.45</td>
</tr>
<tr>
<td>
<italic>B. monosperma</italic> (200 mg/kg) in VIN </td>
<td>4.38 ± 0.27<sup>bc</sup>
</td>
<td>51.37 ± 2.12<sup>bc</sup>
</td>
<td>18.94 ± 0.52<sup>bc</sup>
</td>
</tr>
<tr>
<td>
<italic>B. monosperma</italic> (300 mg/kg) in VIN</td>
<td>3.96 ± 0.62<sup>d</sup>
</td>
<td>63.18 ± 2.41<sup>d</sup>
</td>
<td>10.93 ± 0.32<sup>d</sup>
</td>
</tr>
<tr>
<td>
<italic>B. monosperma</italic> (400 mg/kg) in VIN</td>
<td>3.33 ± 0.41<sup>d</sup>
</td>
<td>70.24 ± 1.58<sup>d</sup>
</td>
<td>6.85 ± 0.52<sup>d</sup>
</td>
</tr>
<tr>
<td>Pregabalin (10 mg/kg) in VIN</td>
<td>3.29 ± 0.35<sup>d</sup>
</td>
<td>73.84 ± 1.74<sup>d</sup>
</td>
<td>4.57 ± 0.42<sup>d</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0748233711432573">
<p>MDA: malondialdehyde; GSH: glutathione; VIN: vincristine.</p>
</fn>
<fn id="table-fn2-0748233711432573">
<p>
<sup>a</sup>Levels of MDA, GSH, and total calcium were determined in sciatic nerve of different groups. Data were expressed as mean ± SEM, <italic>n </italic>= 6 rats per group.</p>
</fn>
<fn id="table-fn3-0748233711432573">
<p>
<sup>b</sup>
<italic>p </italic>&lt; 0.05 versus normal control group.</p>
</fn>
<fn id="table-fn4-0748233711432573">
<p>
<sup>c</sup>
<italic>p </italic>&lt; 0.05 versus pregabalin-treated group.</p>
</fn>
<fn id="table-fn5-0748233711432573">
<p>
<sup>d</sup>
<italic>p </italic>&lt; 0.05 versus <italic>B. monosperma</italic> control group.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section18-0748233711432573">
<title>Effect of <italic>B. monosperma</italic> on histopathological changes</title>
<p>Vincristine administration resulted in significant histopathological changes that are assessed in transverse section of the sciatic nerve. In transverse section, nerve derangement, axonal swelling and increase in the number of Schwann and satellite cells were also noted. Administration of the ethanolic extract of <italic>B. monosperma </italic>(200, 300 and 400 mg/kg; p.o.) significantly attenuated vincristine-induced axonal degeneration and histopathological alterations (<xref ref-type="fig" rid="fig6-0748233711432573">Figure 6</xref>).</p>
<fig id="fig6-0748233711432573" position="float">
<label>Figure 6.</label>
<caption>
<p>Effect of <italic>Butea monosperma </italic>on histopathological changes. Figures (a–f) show transverse section of sciatic nerve of normal, vincristine, <italic>B. monosperma</italic> (200, 300 and 400 mg/kg) and pregabalin-pretreated groups, respectively. In the figures, thin arrow shows axonal swelling, bold arrow shows vincristine-induced decrease in the number of myelinated fibres and arrow head shows swelling of nerve fibre arrangement. Figures (b–d) show vincristine-induced axonal swelling, derangement of nerve fibres and swelling of myelinated and nonmyelinated fibres. In (d–<xref ref-type="fig" rid="fig6-0748233711432573">f</xref>), pretreatment of <italic>B. monosperma </italic>(300 and 400 mg/kg) and pregabalin shows decrease in the vincristine-induced histopathological changes. Microscopic examinations were performed under light microscopy at a magnification of ×450, scale bar = 35 µm.</p>
</caption>
<graphic xlink:href="10.1177_0748233711432573-fig6.tif"/>
</fig>
</sec>
</sec>
<sec id="section19-0748233711432573">
<title>Discussion</title>
<p>In the present study, ethanolic extract of <italic>B. monosperma </italic>significantly attenuated vincristine-induced behavioural (i.e. paw and tail heat hyperalgesia, cold allodynia, mechanical hyperalgesia and mechanical allodynia) and biochemical (TBARS, total calcium and reduced GSH) as well as histopathological changes. The behavioural alterations started from day 3 and maximal nociceptive threshold was observed on day 9 by vincristine (50 µg/kg; IP once a day, for 10 consecutive days) administration. These observations are in line with the earlier findings of our colleagues (<xref ref-type="bibr" rid="bibr28-0748233711432573">Muthuraman et al., 2008a</xref>, <xref ref-type="bibr" rid="bibr31-0748233711432573">2010</xref>) and reports from the other laboratories (<xref ref-type="bibr" rid="bibr51-0748233711432573">Sweitzer et al., 2006</xref>; <xref ref-type="bibr" rid="bibr52-0748233711432573">Topp et al., 2000</xref>).</p>
<p>Vincristine has been widely used for the management of various life-threatening cancer disorders including Hodgkin’s disease. However, its clinical application has been limited due to unavoidable painful ‘dying-back’ neuropathy. It possesses the property of high binding affinity towards β-tubulin of microtubules of peripheral nervous system. Microtubules are key components of the cytoskeleton and are composed of heterodimers of α-tubulin and β-tubulin, which assemble into linear, hollow, cytoplasmic filaments (<xref ref-type="bibr" rid="bibr40-0748233711432573">Schwartz, 2009</xref>). Vincristine has been documented to cause disruption of microtubule polymerizations leading to destabilize microtubules, block proliferation by cell cycle arrest and cause cell death via the induction of apoptosis for its chemotherapeutic as well as neurotoxic actions (<xref ref-type="bibr" rid="bibr17-0748233711432573">Jordan and Wilson, 2004</xref>).</p>
<p>Furthermore, Vincristine has also been reported to alter the cellular Ca<sup>2+</sup> and free radical levels (<xref ref-type="bibr" rid="bibr19-0748233711432573">Kamei et al., 2005</xref>; <xref ref-type="bibr" rid="bibr47-0748233711432573">Siau and Bennett, 2006</xref>), which play a key role in the pathogenesis of painful dying-back neuropathy associated with vincristine. Calcium-induced free radical generation have been implicated to potential neuronal injury (<xref ref-type="bibr" rid="bibr28-0748233711432573">Muthuraman et al., 2008a</xref>, <xref ref-type="bibr" rid="bibr29-0748233711432573">2008b</xref>, <xref ref-type="bibr" rid="bibr31-0748233711432573">2010</xref>; <xref ref-type="bibr" rid="bibr32-0748233711432573">Muthuraman and Sood, 2010</xref>). Calcium accumulation has been triggered as a self-destructive cascade via calcium-binding protein such as calmodulin and calpain leading to neuronal hyperexcitability, adenosine triphosphate depletion, free radical generation and activation of cytosolic phospholipases and proteases (<xref ref-type="bibr" rid="bibr28-0748233711432573">Muthuraman et al., 2008a</xref>, <xref ref-type="bibr" rid="bibr29-0748233711432573">2008b</xref>, <xref ref-type="bibr" rid="bibr31-0748233711432573">2010</xref>; <xref ref-type="bibr" rid="bibr57-0748233711432573">Xie and Barrett, 1991</xref>; <xref ref-type="bibr" rid="bibr58-0748233711432573">Young, 1992</xref>). Calcium-induced activation of calpains has also been reported to degrade axonal cytoskeleton resulting in the axonal degeneration via β-tubulin polymerization (<xref ref-type="bibr" rid="bibr13-0748233711432573">Glass et al., 2002</xref>). In turn, free radicals are also documented to induce potential tissue damage and painful neuropathy (<xref ref-type="bibr" rid="bibr36-0748233711432573">Park et al., 2010</xref>; <xref ref-type="bibr" rid="bibr28-0748233711432573">Muthuraman et al., 2008a</xref>). Moreover, calcium accumulation and free radical generations have been documented as a major culprit event in various types of neuropathic pain disorders like posttraumatic, axotomy, anti-HIV drugs, tibial sural transaction, chronic constriction injury, ischemic–reperfusion injury and vincristine-induced neuropathy (<xref ref-type="bibr" rid="bibr28-0748233711432573">Muthuraman et al., 2008a</xref>, <xref ref-type="bibr" rid="bibr29-0748233711432573">2008b</xref>
<xref ref-type="bibr" rid="bibr31-0748233711432573">, 2010</xref>). In the present study, vincristine treatment resulted in the rise in the levels of TBARS (an index of lipid peroxidation) and total calcium and fall in the reduced GSH (an endogenous antioxidant molecule), thus supporting the contention that free radicals may contribute in pathogenesis of neuropathy. Moreover, the administration of ethanolic extract of <italic>B. monosperma </italic>significantly attenuated the vincristine-induced alterations of peripheral and central behavioural and oxidative stress marker changes as well as histopathological changes. Experimentally, <italic>B. monosperma </italic>has been documented to decrease free radical generation via enhancement of antioxidant mechanisms (<xref ref-type="bibr" rid="bibr38-0748233711432573">Sai Krishna et al., 2010</xref>). The decrease in calcium levels with <italic>B. monosperma </italic>may be attributed to its antioxidant effects via free radical scavenging and calcium channel inhibitory actions (<xref ref-type="bibr" rid="bibr14-0748233711432573">Lavhale and Mishra, 2007</xref>). However, the possibility of direct action of <italic>B. monosperma </italic>on calcium channel and decrease in calcium levels may not also be ruled out. However, number of experimental reports indicates antioxidant effects of <italic>B. monosperma </italic>in various studies (<xref ref-type="bibr" rid="bibr14-0748233711432573">Lavhale and Mishra, 2007</xref>; <xref ref-type="bibr" rid="bibr38-0748233711432573">Sai Krishna et al., 2010</xref>; <xref ref-type="bibr" rid="bibr45-0748233711432573">Sharrna and Garg, 2009</xref>). <italic>B. monosperma </italic>has significantly attenuated vincristine-induced hyperalgesic and allodynic pain sensation and biochemical as well as histopathological changes. Similar results were obtained in the pregabalin-treated animals. Pregabalin is a potential voltage-dependent N-type calcium channel blocker (selectively bind to α2-δ subunit; <xref ref-type="bibr" rid="bibr23-0748233711432573">Kumar et al., 2010</xref>). It has also been reported to possess the potential role in the management of painful neuropathy in human as well as in experimental animal (<xref ref-type="bibr" rid="bibr5-0748233711432573">Bender et al., 2010</xref>; <xref ref-type="bibr" rid="bibr30-0748233711432573">Muthuraman et al., 2011</xref>). Ameliorative effect of <italic>B. monosperma </italic>against vincristine-induced neuropathic pain may be due to its free radical scavenging and calcium channel modulatory actions. Nevertheless, further studies are needed to substantiate these findings.</p>
</sec>
<sec id="section20-0748233711432573">
<title>Conclusion</title>
<p>Hence, ethanolic extract of <italic>B. monosperma </italic>possesses the therapeutic potential on vincristine-induced behavioural, biochemical and histopathological changes in rats. These ameliorative effects may be attributed due to its antioxidative, anti-inflammatory, neuroprotective and calcium channel inactivating potential.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors thank Drs N. Chidambara Nathan, Department of Pharmacology, K.M. College of Pharmacy, Madurai, K. Raadhika, Institute of Pharmacology, Madurai Medical College, Madurai, for their valuable suggestions and support to carry out this work.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-0748233711432573">
<label>Conflict of interest</label>
<p>The authors declared no conflicts of interest.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0748233711432573">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gmünder</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hamburger</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>Plants traditionally used in age related brain disorders—a survey of ethnobotanical literature</article-title>. <source>Journal of Ethnopharmacology</source> <volume>113</volume>(<issue>3</issue>): <fpage>363</fpage>–<lpage>381</lpage>.</citation>
</ref>
<ref id="bibr2-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. (<year>1994</year>) <article-title>Management of giardiasis by an immuno-modulatory herbal drug Pippali rasayana</article-title>. <source>Journal of Ethnopharmacology</source> <volume>44</volume>(<issue>3</issue>): <fpage>143</fpage>–<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr3-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname>
<given-names>AK.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Sahai</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>Management of giardiasis by a herbal drug Pippali Rasayana: a clinical study</article-title>. <source>Journal of Ethnopharmacology</source> <volume>56</volume>(<issue>3</issue>): <fpage>233</fpage>–<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr4-0748233711432573">
<citation citation-type="book">
<collab collab-type="author">Anonymous</collab> (<year>2006</year>) <source>The Ayurvedic Pharmacopoeia of India</source>. <publisher-loc>New Delhi</publisher-loc>: <publisher-name>Government of India</publisher-name>, pp. <fpage>128</fpage>–<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr5-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bender</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Florian</surname>
<given-names>JA</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Bramwell</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain</article-title>. <source>Journal of Pharmacology and Experimental Therapeutics</source> <volume>334</volume>(<issue>2</issue>): <fpage>599</fpage>–<lpage>608</lpage>.</citation>
</ref>
<ref id="bibr6-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carol</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jane</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Evidence-based treatment of diabetic peripheral neuropathy</article-title>. <source>Journal of Nurse Practitioners</source> <volume>2</volume>: <fpage>370</fpage>–<lpage>378</lpage>.</citation>
</ref>
<ref id="bibr7-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaplan</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Pogrel</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yaksh</surname>
<given-names>TL</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Quantitative assessment of tactile allodynia in the rat paw</article-title>. <source>Journal of Neuroscience Methods</source> <volume>53</volume>(<issue>1</issue>): <fpage>55</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr8-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>Y</given-names> </name>
<name>
<surname>Yoon</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>JM</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain</article-title>. <source>Pain</source> <volume>59</volume>(<issue>3</issue>): <fpage>369</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr9-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dworkin</surname>
<given-names>RH</given-names> </name>
<name>
<surname>O’Connor</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Audette</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Recommendations for the pharmacological management of neuropathic pain: an overview and literature update</article-title>. <source>Mayo Clinic Proceedings</source> <volume>85</volume>(<issue>3 suppl</issue>): <fpage>S3</fpage>–<lpage>S14</lpage>.</citation>
</ref>
<ref id="bibr10-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eddy</surname>
<given-names>NB</given-names> </name>
<name>
<surname>Touchberry</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>JE</given-names>
</name>
</person-group> (<year>1950</year>) <article-title>Synthetic analgesics: I. Methadone isomers and derivatives</article-title>. <source>Journal of Pharmacology and Experimental Therapeutics</source> <volume>98</volume>(<issue>2</issue>): <fpage>121</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr11-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellis</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Toperoff</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Vaida</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial</article-title>. <source>Neuropsychopharmacology</source> <volume>34</volume>(<issue>3</issue>): <fpage>672</fpage>–<lpage>680</lpage>.</citation>
</ref>
<ref id="bibr12-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellman</surname>
<given-names>GL</given-names>
</name>
</person-group> (<year>1959</year>) <article-title>Tissue sulfhydryl groups</article-title>. <source>Archives of Biochemistry and Biophysics</source> <volume>82</volume>: <fpage>70</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr13-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glass</surname>
<given-names>JD</given-names> </name>
<name>
<surname>Culver</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Levey</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Nash</surname>
<given-names>NR</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Very early activation of m-calpain in peripheral nerve during Wallerian degeneration</article-title>. <source>Journal of Neurological Science</source> <volume>196</volume>(<issue>1-2</issue>): <fpage>9</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr14-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lavhale</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>SH</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>Evaluation of free radical scavenging activity of <italic>Butea monosperma</italic> Lam</article-title>. <source>Indian Journal of Experimental Biology</source> <volume>45</volume>(<issue>4</issue>): <fpage>376</fpage>–<lpage>384</lpage>.</citation>
</ref>
<ref id="bibr15-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higuera</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>David Luo</surname>
<given-names>Z</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>A rat pain model of vincristine-induced neuropathy</article-title>. <source>Methods in Molecular Medicine</source> <volume>99</volume>: <fpage>91</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr16-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaggi</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats</article-title>. <source>European Journal of Pharmacology</source> <volume>648</volume>(<issue>1-3</issue>): <fpage>102</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr17-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jordan</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>L</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Microtubules as a target for anticancer drugs</article-title>. <source>Nature Reviews. Cancer</source> <volume>4</volume>(<issue>4</issue>): <fpage>253</fpage>–<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr18-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaley</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Deangelis</surname>
<given-names>LM</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Therapy of chemotherapy-induced peripheral neuropathy</article-title>. <source>British Journal of Haematology</source> <volume>145</volume>(<issue>1</issue>): <fpage>3</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr19-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamei</surname>
<given-names>J</given-names> </name>
<name>
<surname>Tamura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Saitoh</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice</article-title>. <source>Pain</source> <volume>117</volume>(<issue>1-2</issue>): <fpage>112</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr20-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasture</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Chopde</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Deshmukh</surname>
<given-names>VK</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>) <article-title>Anticonvulsive activity of <italic>Albizzia lebbeck, Hibiscus rosasinensis</italic>, and <italic>Butea monosperma</italic> in experimental animals</article-title>. <source>Journal of Ethnopharmacology</source> <volume>71</volume>(<issue>1-2</issue>): <fpage>65</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr21-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YS</given-names> </name>
<name>
<surname>Park</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>The effects of <italic>Ginkgo biloba </italic>extract EGb 761 on mechanical and cold allodynia in a rat model of neuropathic pain</article-title>. <source>Anesthesia and Analgesia</source> <volume>108</volume>(<issue>6</issue>): <fpage>1958</fpage>–<lpage>1963</lpage>.</citation>
</ref>
<ref id="bibr22-0748233711432573">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Krithikar</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>BD</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Butea monosperma</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Blatter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Caius</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Mahaskar</surname>
<given-names>KS</given-names>
</name>
</person-group> (eds) <source>Indian Medicinal Plants</source>. <publisher-loc>Dehradun</publisher-loc>: <publisher-name>Shiva Offset Press</publisher-name>, pp. <fpage>785</fpage>–<lpage>788</lpage>.</citation>
</ref>
<ref id="bibr23-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Laferriere</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Leavitt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coderre</surname>
<given-names>TJ</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate</article-title>. <source>Journal of Neurochemistry</source> <volume>113</volume>(<issue>2</issue>): <fpage>552</fpage>–<lpage>561</lpage>.</citation>
</ref>
<ref id="bibr24-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nandi</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Improving the management of neuropathic pain</article-title>. <source>Practitioner</source> <volume>254</volume>(<issue>1731</issue>): <fpage>27</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr25-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowry</surname>
<given-names>OH</given-names> </name>
<name>
<surname>Rosenbrough</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Farr</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Randall</surname>
<given-names>RJ</given-names>
</name>
</person-group> (<year>1951</year>) <article-title>Protein measurement with folin phenol reagent</article-title>. <source>Journal of Biological Chemistry</source> <volume>193</volume>(<issue>1</issue>): <fpage>265</fpage>–<lpage>275</lpage>.</citation>
</ref>
<ref id="bibr26-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manyam</surname>
<given-names>BV</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Dementia in ayurveda</article-title>. <source>Journal of Alternative and Complementary Medicine</source> <volume>5</volume>(<issue>1</issue>): <fpage>81</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr27-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mengi</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Deshpande</surname>
<given-names>SG</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Evaluation of ocular anti-inflammatory activity of <italic>Butea frondosa</italic>
</article-title>. <source>Indian Journal of Pharmacology</source> <volume>27</volume>: <fpage>116</fpage>–<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr28-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthuraman</surname>
<given-names>A</given-names> </name>
<name>
<surname>Jaggi</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2008a</year>) <article-title>Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine-induced painful neuropathy in rats</article-title>. <source>European Journal of Pharmacology</source> <volume>587</volume>(<issue>1-3</issue>): <fpage>104</fpage>–<lpage>111</lpage>.</citation>
</ref>
<ref id="bibr29-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthuraman</surname>
<given-names>A</given-names> </name>
<name>
<surname>Diwan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Jaggi</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2008b</year>) <article-title>Ameliorative effects of <italic>Ocimum sanctum</italic> in sciatic nerve transection induced neuropathy in rats</article-title>. <source>Journal of Ethnopharmacology</source> <volume>120</volume>(<issue>1</issue>): <fpage>56</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr30-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthuraman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jaggi</surname>
<given-names>AS</given-names>
</name>
</person-group> (<year>2011</year>) <article-title>Effect of hydroalcoholic extract of <italic>Acorus calamus</italic> on tibial and sural nerve transection-induced painful neuropathy in rats</article-title>. <source>Journal of Natural Medicine</source> <volume>65</volume>(<issue>2</issue>): <fpage>282</fpage>–<lpage>292</lpage>.</citation>
</ref>
<ref id="bibr31-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthuraman</surname>
<given-names>A</given-names> </name>
<name>
<surname>Ramesh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sood</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Development of animal model for vasculatic neuropathy: induction by ischemic-reperfusion in the rat femoral artery</article-title>. <source>Journal of Neuroscience Methods</source> <volume>186</volume>(<issue>2</issue>): <fpage>215</fpage>–<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr32-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthuraman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sood</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Pharmacological evaluation of tacrolimus (FK-506) on ischemia reperfusion induced vasculatic neuropathic pain in rats</article-title>. <source>Journal of Brachial Plexus Peripheral Nerve Injury</source> <volume>5</volume>: <fpage>13</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr33-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Necker</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hellon</surname>
<given-names>RF</given-names>
</name>
</person-group> (<year>1978</year>) <article-title>Noxious thermal input from the rat tail: modulation by descending inhibitory influences</article-title>. <source>Pain</source> <volume>4</volume>(<issue>3</issue>): <fpage>231</fpage>–<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr34-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nurmikko</surname>
<given-names>TJ</given-names> </name>
<name>
<surname>Serpell</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Hoggart</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Toomey</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Morlion</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial</article-title>. <source>Pain</source> <volume>133</volume>(<issue>1-3</issue>): <fpage>210</fpage>–<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr35-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okhawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohishi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>1979</year>) <article-title>Assay for lipid peroxidation in animal tissue by thiobarbituric acid reaction</article-title>. <source>Analytical Biochemistry</source> <volume>95</volume>: <fpage>351</fpage>–<lpage>358</lpage>.</citation>
</ref>
<ref id="bibr36-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>HW</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Antinociceptive effect of memantine and morphine on vincristine-induced peripheral neuropathy in rats</article-title>. <source>Korean Journal of Pain</source> <volume>23</volume>(<issue>3</issue>): <fpage>179</fpage>–<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr37-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Randall</surname>
<given-names>LO</given-names>
</name>
<name>
<surname>Selitto</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>1957</year>) <article-title>A method for measurement of analgesic activity of inflamed tissue</article-title>. <source>Archives Internationales de Pharmacodynamie et de Therapie</source> <volume>111</volume>: <fpage>209</fpage>–<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr38-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sai Krishna</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ranganayakulu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sujatha</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pushpa kumara</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Venkateswarulu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>GopiChand</surname>
<given-names>Chinta</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Anti-oxidant activity of the <italic>Butea monosperma</italic> leaves alone and in combination with atrovastatin</article-title>. <source>Drug Invention Today</source> <volume>2</volume>: <fpage>149</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr39-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandler</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Tobin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>ES</given-names>
</name>
</person-group> (<year>1969</year>) <article-title>Vincristine-induced neuropathy. A clinical study of fifty leukemic patients</article-title>. <source>Neurology</source> <volume>19</volume>(<issue>4</issue>): <fpage>367</fpage>–<lpage>374</lpage>.</citation>
</ref>
<ref id="bibr40-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>EL</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Antivascular actions of microtubule-binding drugs</article-title>. <source>Clinical Cancer Research</source> <volume>15</volume>(<issue>8</issue>): <fpage>2594</fpage>–<lpage>2601</lpage>.</citation>
</ref>
<ref id="bibr41-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sehrawat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Chemoprevention by <italic>Butea monosperma</italic> of hepatic carcinogenesis and oxidative damage in male Wistar rats</article-title>. <source>Asian Pacific Journal of Cancer Prevention</source> <volume>7</volume>(<issue>1</issue>): <fpage>140</fpage>–<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr42-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severinghaus</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Ferrebee</surname>
<given-names>JW</given-names>
</name>
</person-group> (<year>1950</year>) <article-title>Calcium determination by flame photometry; methods for serum, urine, and other fluids</article-title>. <source>Journal of Biological Chemistry</source> <volume>187</volume>(<issue>2</issue>): <fpage>621</fpage>–<lpage>630</lpage>.</citation>
</ref>
<ref id="bibr43-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahavi</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>SK</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Anti-inflammatory activity of <italic>Butea monosperma</italic> flowers</article-title>. <source>Fitoterapia</source> <volume>79</volume>(<issue>2</issue>): <fpage>82</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr44-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>V</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Antidiabetic and antioxidant potential of ethanolic extract of <italic>Butea monosperma </italic>leaves in alloxan-induced diabetic mice</article-title>. <source>Indian Journal of Biochemistry and Biophysics</source> <volume>46</volume>(<issue>1</issue>): <fpage>99</fpage>–<lpage>105</lpage>.</citation>
</ref>
<ref id="bibr45-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharrna</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>V</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Antihyperglycemic and antioxidative potential of hydroalcoholic extract of <italic>Butea monosperma. </italic>Lam. flowers in alloxan-induced diabetic mice</article-title>. <source>Indian Journal of Experimental Biology</source> <volume>47</volume>(<issue>7</issue>): <fpage>571</fpage>–<lpage>576</lpage>.</citation>
</ref>
<ref id="bibr46-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname>
<given-names>YN</given-names> </name>
<name>
<surname>Mishra</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sushil</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Euphane triterpenoid ester and a pterocarpan fron <italic>Butea monosperma</italic> leaves</article-title>. <source>Indian Journal of Chemistry</source> <volume>41B</volume>: <fpage>881</fpage>–<lpage>883</lpage>.</citation>
</ref>
<ref id="bibr47-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>GJ</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Dysregulation of neuronal calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy</article-title>. <source>Anesthesia and Analgesia</source> <volume>102</volume>(<issue>5</issue>): <fpage>1485</fpage>–<lpage>1490</lpage>.</citation>
</ref>
<ref id="bibr48-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soman</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mengi</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kasture</surname>
<given-names>SB</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Effect of leaves of<italic> Butea frondosa </italic>on stress, anxiety, and cognition in rats</article-title>. <source>Pharmacology, Biochemistry, and Behavior</source> <volume>79</volume>(<issue>1</issue>): <fpage>11</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr49-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudoh</surname>
<given-names>Y</given-names> </name>
<name>
<surname>Desai</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Haderer</surname>
<given-names>AE</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>) <article-title>Neurologic and histopathologic evaluation after high volume intrathecal amitriptyline</article-title>. <source>Regional Anesthesia and Pain Medicine</source> <volume>29</volume>(<issue>5</issue>): <fpage>434</fpage>–<lpage>440</lpage>.</citation>
</ref>
<ref id="bibr50-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzgec-Selcuk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Birteksoz</surname>
<given-names>AS</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Flavonoids of Helichrysum chasmolycicum and its antioxidant and antimicrobial activities</article-title>. <source>South African Journal of Botany</source> <volume>77</volume>: <fpage>170</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr51-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sweitzer</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Pahl</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>DeLeo</surname>
<given-names>JA</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat</article-title>. <source>Neuroscience Letters</source> <volume>400</volume>(<issue>3</issue>): <fpage>258</fpage>–<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr52-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Topp</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Tanner</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>JD</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine induced painful peripheral neuropathy in the rat</article-title>. <source>Journal of Comparative Neurology</source> <volume>424</volume>(<issue>4</issue>): <fpage>563</fpage>–<lpage>576</lpage>.</citation>
</ref>
<ref id="bibr53-0748233711432573">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Varier</surname>
<given-names>SPV</given-names>
</name>
</person-group> (<year>1995</year>) <source>Indian Medicinal Plants</source>. <publisher-loc>Madras</publisher-loc>: <publisher-name>Long Man Publisher</publisher-name>.</citation>
</ref>
<ref id="bibr54-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weimer</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Sachdev</surname>
<given-names>N</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Update on medication-induced peripheral neuropathy</article-title>. <source>Current Neurology and Neuroscience Reports</source> <volume>9</volume>(<issue>1</issue>): <fpage>69</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr55-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiffen</surname>
<given-names>PJ</given-names> </name>
<name>
<surname>Collins</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McQuay</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jadad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>RA</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>WITHDRAWN. Anticonvulsant drugs for acute and chronic pain</article-title>. <source>Cochrane Database of Systemic Reviews</source> <volume>1</volume>: <fpage>CD001133</fpage>.</citation>
</ref>
<ref id="bibr56-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolf</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Mannion</surname>
<given-names>RJ</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Neuropathic pain: aetiology, symptoms, mechanisms, and management</article-title>. <source>Lancet</source> <volume>353</volume>(<issue>9168</issue>): <fpage>1959</fpage>–<lpage>1964</lpage>.</citation>
</ref>
<ref id="bibr57-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>JN</given-names>
</name>
</person-group> (<year>1991</year>) <article-title>Membrane resealing in cultured rat septal neurons after neurite transection: evidence for enhancement by Ca(2+)-triggered protease activity and cytoskeletal disassembly</article-title>. <source>Journal of Neuroscience</source> <volume>11</volume>(<issue>10</issue>): <fpage>3257</fpage>–<lpage>3267</lpage>.</citation>
</ref>
<ref id="bibr58-0748233711432573">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>W</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Role of calcium in central nervous system injuries</article-title>. <source>Journal of Neurotrauma</source> <volume>9</volume>(<issue>suppl 1</issue>): <fpage>9</fpage>–<lpage>25</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>